Kevin C. Colclough

Exeter, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Clinical Utility of a Type 1 Diabetes Genetic Risk Score Measured as Part of MODY Genetic Testing.

Clinical Utility of a Type 1 Diabetes Genetic Risk Score Measured as Part of MODY Genetic Testing.

Journal: Diabetes care

Published: May 14, 2026

Familial medullary thyroid carcinoma secondary to an SLC30A9 intragenic deletion and translation reinitiation.

Familial medullary thyroid carcinoma secondary to an SLC30A9 intragenic deletion and translation reinitiation.

Journal: medRxiv : the preprint server for health sciences

Published: March 18, 2026

Identification of Nuclear Genetic Loci Linked to Clinical Features of the m.3243A>G Mitochondrial DNA Variant.

Identification of Nuclear Genetic Loci Linked to Clinical Features of the m.3243A>G Mitochondrial DNA Variant.

Journal: Neurology. Genetics

Published: November 10, 2025

Loss of function variants in the primate-specific gene ZNF808 cause neonatal, transient and adult-onset diabetes.

Loss of function variants in the primate-specific gene ZNF808 cause neonatal, transient and adult-onset diabetes.

Journal: EBioMedicine

Published: October 17, 2025

Polygenic background contributes to GCK-MODY clinical presentation and glycaemic variability.

Polygenic background contributes to GCK-MODY clinical presentation and glycaemic variability.

Journal: Diabetologia

Published: October 13, 2025

Genotype-first approach reveals monogenic lipodystrophy is underdiagnosed, with health and mortality risks.

Genotype-first approach reveals monogenic lipodystrophy is underdiagnosed, with health and mortality risks.

Journal: EBioMedicine

Published: September 30, 2025

Systematic analysis of loss-of-function variants across MODY genes demonstrates gene-specific effects and expands the spectrum of INS variants causing MODY.

Systematic analysis of loss-of-function variants across MODY genes demonstrates gene-specific effects and expands the spectrum of INS variants causing MODY.

Journal: Diabetologia

Published: August 27, 2025

A new form of diabetes caused by INS mutations defined by zygosity, stem cell and population data.

A new form of diabetes caused by INS mutations defined by zygosity, stem cell and population data.

Journal: EMBO molecular medicine

Published: July 11, 2025

Population Prevalence, Penetrance, and Mortality for Genetically Confirmed MODY.

Population Prevalence, Penetrance, and Mortality for Genetically Confirmed MODY.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 01, 2025

MODY Is Prevalent in Later-Onset Diabetes and Has Potential for Targeted Therapy but Is Challenging to Identify.

MODY Is Prevalent in Later-Onset Diabetes and Has Potential for Targeted Therapy but Is Challenging to Identify.

Journal: Diabetes

Published: June 10, 2025

Common genetic variants modify disease risk and clinical presentation in monogenic diabetes.

Common genetic variants modify disease risk and clinical presentation in monogenic diabetes.

Journal: Nature metabolism

Published: May 28, 2025

Sulphonylurea efficacy and end-organ outcomes in the management of HNF4A-MODY.

Sulphonylurea efficacy and end-organ outcomes in the management of HNF4A-MODY.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: May 22, 2025

Showing 1-12 of 79

Last Updated: 09/26/2026